These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1871054)

  • 21. Adsorption of methotrexate and calcium leucovorin onto cholestyramine in vitro.
    Merino-Sanjuán M; Carrera A; Monte E; Jiménez-Torres NV
    Int J Pharm; 2004 Jul; 278(2):283-91. PubMed ID: 15196633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cholestyramine and activated charcoal on glipizide absorption.
    Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1990 Nov; 30(5):733-6. PubMed ID: 2271372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlative studies of the hypocholesterolemic effect of a highly activated charcoal.
    Tishler PV; Winston SH; Bell SM
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):799-806. PubMed ID: 3441164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceleration of the elimination of tenoxicam by cholestyramine in the dog.
    Guentert TW; Schmitt M; Defoin R
    J Pharmacol Exp Ther; 1986 Jul; 238(1):295-301. PubMed ID: 3723402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cholestyramine and colestipol on the absorption of phenytoin.
    Callaghan JT; Tsuru M; Holtzman JL; Hunninghake DB
    Eur J Clin Pharmacol; 1983; 24(5):675-8. PubMed ID: 6873150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of colestipol hydrochloride on drug absorption in the rat II.
    Phillips WA; Ratchford JM; Schultz JR
    J Pharm Sci; 1976 Sep; 65(9):1285-91. PubMed ID: 966139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sorbent therapy of the porphyrias. V. Adsorption of the porphyrin precursors delta-aminolevulinic acid and porphobilinogen by sorbents in vitro.
    Winston SH; Tishler PV
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):233-7. PubMed ID: 3724299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New microporous cholestyramine analog for treatment of hypercholesterolemia.
    De Simone R; Conti F; Lovati MR; Sirtori M; Cocuzza E; Sirtori CR
    J Pharm Sci; 1978 Dec; 67(12):1695-8. PubMed ID: 722483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug interactions in the use of cardiac glycosides].
    Wirth KE
    Med Welt; 1981 Feb; 32(7):234-8. PubMed ID: 7010063
    [No Abstract]   [Full Text] [Related]  

  • 31. Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine.
    Neuvonen PJ; Kuusisto P; Vapaatalo H; Manninen V
    Eur J Clin Pharmacol; 1989; 37(3):225-30. PubMed ID: 2612535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances on the use of adsorbent materials for detoxification of Fusarium mycotoxins.
    Avantaggiato G; Solfrizzo M; Visconti A
    Food Addit Contam; 2005 Apr; 22(4):379-88. PubMed ID: 16019808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation.
    al-Shareef AH; Buss DC; Allen EM; Routledge PA
    Hum Exp Toxicol; 1990 May; 9(3):179-82. PubMed ID: 2375885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramine.
    Ferry DG; Gazeley LR; Busby WJ; Beasley DM; Edwards IR; Campbell AJ
    Eur J Clin Pharmacol; 1990; 39(6):599-601. PubMed ID: 2095346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug adsorption to charcoals and anionic binding resins.
    al-Shareef AH; Buss DC; Routledge PA
    Hum Exp Toxicol; 1990 Mar; 9(2):95-7. PubMed ID: 2340197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver.
    Branch RA; Cotham R; Johnson R; Porter J; Desmond PV; Schenker S
    J Lab Clin Med; 1983 Nov; 102(5):805-12. PubMed ID: 6631171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.
    Herman RJ; Van Pham JD; Szakacs CB
    Clin Pharmacol Ther; 1989 Jul; 46(1):18-25. PubMed ID: 2743706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
    Kinosian BP; Eisenberg JM
    JAMA; 1988 Apr; 259(15):2249-54. PubMed ID: 3127607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dieldrin-14C elimination from turkeys.
    Davison KL; Sell JL
    Arch Environ Contam Toxicol; 1978; 7(2):245-55. PubMed ID: 677948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vitro experiment on the interaction of charcoal or wheat bran with 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol and its glucuronide.
    Skopp G; Mikus G
    Anal Bioanal Chem; 2013 Nov; 405(29):9449-53. PubMed ID: 24077855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.